Penumbra jumps on Boston Scientific's $14.5 billion buyout deal
** Shares of medical equipment maker Penumbra PEN.N rise 13.6% to $356 premarket ** Boston Scientific BSX.N says it will buy Penumbra in a deal valued at about $14.5 billion ** The transaction values each Penumbra share at $374, a premium of 19.3% to the stock's last close ** The deal is expected to be completed later this year ** PEN shares rose 29.6% in 2025 (Reporting by Christy Santhosh) ((Christy.Santhosh@thomsonreuters.com))
Recent news on Boston Scientific
See all newsFactbox: Major deals involving US drugmakers and biotechs over the past decade
U.S. RESEARCH ROUNDUP-Autodesk, Dell Technologies, Hyatt Hotels
Live Markets: Eight trillion reasons UBS wants you to bet on longevity
S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT
U.S. STOCKS ON THE MOVE-Boston Scientific, Banc of California, Salesforce